Sort
130,381 grants matching “hiv”
Development of NNRTI's as Combination Microbicides
$1,681,574Magee-Women'S Res Inst And Foundation · U19 · FY2005 · AI
Immunobiology, molecular virology and countermeasures of highly pathogenic viruses
$1,681,467Andrea Marzi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
GHESKIO HIV Clinical Trial Unit
$1,681,233Jean William Pape · Gheskio Center · U01 · FY2007 · AI
CELLULAR/MOLECULAR PATHOPHYSIOLOGY OF MENTAL RETARDATION
$1,681,152Burnham Institute For Medical Research · P01 · FY2003 · HD
High-Definition Characterization of the Persistence and Perturbation of the HIV Reservoir
$1,681,120Jonathan Li · Brigham And Women'S Hospital · P01 · FY2024 · AI
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
$1,681,031Beth Israel Medical Ctr (New York) · U01 · FY2005 · AI
Intravaginal Ring Delivery of Safe & Effective Microbicides to Prevent HIV & HSV
$1,680,903Betsy C. Herold · Albert Einstein College Of Medicine · U19 · FY2009 · AI
Development of Vaccines to Prevent Tuberculosis
$1,680,701Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Development of Vaccines to Prevent Tuberculosis
$1,680,146Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Time Resolved Fluorescence Spectroscopy
$1,680,003Jay R Knutson · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Center for HIV Identification, Prevention, and Treatment Services
$1,680,001Mary J Rotheram-Borus · University Of California Los Angeles · P30 · FY2013 · MH
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
$1,679,994Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2025 · AI
Seattle Clinical Trials Unit
$1,679,850Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
Nonhuman primate scientific research support component
$1,679,615Norman L Letvin · Duke University · UM1 · FY2013 · AI
Center for AIDS Intervention Research Core Support
$1,679,419Jeffrey A. Kelly · Medical College Of Wisconsin · P30 · FY2017 · MH
International Epidemiology Databases to EvaluateAIDS (IeDEA) Renewal 4
$1,678,906Antoine Jaquet · Adera · U01 · FY2024 · AI
ADULT AIDS CLINICAL TRIALS UNIT (ACTU)
$1,678,880University Of Southern California · U01 · FY2005 · AI
Lifespan/Tufts/brown Center for AIDS Research (CFAR)
$1,678,852Susan Cu-Uvin · Miriam Hospital · P30 · FY2016 · AI
The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN)
$1,678,617Chad J Achenbach · Northwestern University · U54 · FY2024 · EB
QUANTITATIVE VIRAL OUTGROWTH ASSAY (QVOA) SERVICE RESOURCE
$1,678,589Roger Ptak · Southern Research Institute · N01 · FY2017 · AI
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
$1,678,538Luis J. Montaner · Wistar Institute · R01 · FY2021 · DA
Stellenbosch University Clinical Trial Unit, Cape Town, South Africa
$1,678,426Mark Fredric Cotton · Stellenbosch University · U01 · FY2007 · AI
CORE SURVEILLANCE AND HIV INCIDENCE SURVEILLANCE
$1,678,352Ling Hsu · San Francisco Department Of Public Health · U62 · FY2010 · PS
Myeloid - T cell interactions that sustain SIV reservoirs during effective antire
$1,678,316Steven Grant Deeks · University Of California, San Francisco · U19 · FY2014 · AI
Immunologic control of HIV-1 through combination bNAbs and biologics.
$1,678,283Marina Caskey · Rockefeller University · U01 · FY2019 · AI